Cargando…
Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?
BACKGROUND: Poor patient outcomes after aneurysmal subarachnoid hemorrhage (SAH) occur due to a multifactorial process, mainly involving cerebral inflammation (CI), delayed cerebral vasospasm (DCVS), and delayed cerebral ischemia, followed by neurodegeneration. CI is mainly triggered by enhanced syn...
Autores principales: | Wanderer, Stefan, Andereggen, Lukas, Mrosek, Jan, Kashefiolasl, Sepide, Schubert, Gerrit Alexander, Marbacher, Serge, Konczalla, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938656/ https://www.ncbi.nlm.nih.gov/pubmed/34039684 http://dx.doi.org/10.1136/neurintsurg-2021-017504 |
Ejemplares similares
-
The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage
por: Wanderer, Stefan, et al.
Publicado: (2020) -
The Effect of Losartan on Neuroinflammation as Well as on Endothelin-1- and Serotonin-Induced Vasoconstriction in a Double-Haemorrhage Rat Model
por: Konczalla, Jürgen, et al.
Publicado: (2022) -
Statins Improve Clinical Outcome After Non-aneurysmal Subarachnoid Hemorrhage: A Translational Insight From a Systematic Review of Experimental Studies
por: Kashefiolasl, Sepide, et al.
Publicado: (2021) -
Does aneurysm side influence the infarction side and patients´ outcome after subarachnoid hemorrhage?
por: Brawanski, Nina, et al.
Publicado: (2019) -
Short- and Long-Term Effects of Rehabilitation after Perimesencephalic Subarachnoid Hemorrhage
por: Schmitz, Jens, et al.
Publicado: (2021)